Methods to control the pharmaceutical cost impact of chronic conditions in the elderly

Expert Rev Pharmacoecon Outcomes Res. 2015 Jun;15(3):425-37. doi: 10.1586/14737167.2015.1017564. Epub 2015 Feb 23.

Abstract

Multimorbidity is the main cause of polypharmacy in elderly people, with the consequent increment in cost and use of inappropriate medication. To control cost, specific strategies have been implemented in healthcare services to reduce potentially inappropriate prescription. Many interventions are applied online during the prescription process using computerized decision support systems, for example, therapeutic algorithms and alerts. Other interventions can be categorized as offline due to their application before or after the prescription process, the main strategies being financial incentives, medication reviews and organizational change. All these strategies are complementary and multifaceted. There is evidence that some of these interventions are effective, but further research should be directed in this field, including investigation of patient cost and outcomes.

Keywords: computerized support systems; cost control; inappropriate prescribing; medication-related problems; multimorbidity; older people; polypharmacy; risk adjustment.

Publication types

  • Review

MeSH terms

  • Aged
  • Algorithms
  • Chronic Disease
  • Decision Support Systems, Clinical
  • Delivery of Health Care / economics
  • Delivery of Health Care / standards
  • Humans
  • Inappropriate Prescribing / economics*
  • Inappropriate Prescribing / prevention & control
  • Polypharmacy*
  • Practice Patterns, Physicians' / economics
  • Practice Patterns, Physicians' / standards*